Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Morphometric analysis of spread platelets identifies integrin αIIbβ3-specific contractile phenotype.

Lickert S, Sorrentino S, Studt JD, Medalia O, Vogel V, Schoen I.

Sci Rep. 2018 Apr 3;8(1):5428. doi: 10.1038/s41598-018-23684-w.

2.

Risk Factors for Higher-than-Expected Residual Rivaroxaban Plasma Concentrations in Real-Life Patients.

Kaserer A, Schedler A, Jetter A, Seifert B, Spahn DR, Stein P, Studt JD.

Thromb Haemost. 2018 May;118(5):808-817. doi: 10.1055/s-0038-1639585. Epub 2018 Apr 3.

PMID:
29614520
3.

The Impact of Prehospital Tranexamic Acid on Blood Coagulation in Trauma Patients.

Stein P, Studt JD, Albrecht R, Müller S, von Ow D, Fischer S, Seifert B, Mariotti S, Spahn DR, Theusinger OM.

Anesth Analg. 2018 Feb;126(2):522-529. doi: 10.1213/ANE.0000000000002708.

4.

Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.

Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M.

J Thromb Haemost. 2017 Aug;15(8):1576-1583. doi: 10.1111/jth.13747. Epub 2017 Jul 17.

PMID:
28574652
5.

Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.

Bulla O, Poncet A, Alberio L, Asmis LM, Gähler A, Graf L, Nagler M, Studt JD, Tsakiris DA, Fontana P.

Haemophilia. 2017 Jul;23(4):e335-e339. doi: 10.1111/hae.13250. Epub 2017 May 24.

PMID:
28544263
6.

Impact of rivaroxaban on point-of-care assays.

Fontana P, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Schmid P, Stricker H, Studt JD, Tsakiris DA, Wuillemin WA, Nagler M.

Thromb Res. 2017 May;153:65-70. doi: 10.1016/j.thromres.2017.03.019. Epub 2017 Mar 21.

PMID:
28343143
7.

Quarantine versus pathogen-reduced plasma-coagulation factor content and rotational thromboelastometry coagulation.

Theusinger OM, Goslings D, Studt JD, Brand-Staufer B, Seifert B, Spahn DR, Frey BM.

Transfusion. 2017 Mar;57(3):637-645. doi: 10.1111/trf.13935. Epub 2016 Nov 27.

PMID:
27891624
8.

Toward correlating structure and mechanics of platelets.

Sorrentino S, Studt JD, Horev MB, Medalia O, Sapra KT.

Cell Adh Migr. 2016 Sep 2;10(5):568-575. Epub 2016 Apr 22. Review.

9.

The macromolecular architecture of platelet-derived microparticles.

Tamir A, Sorrentino S, Motahedeh S, Shai E, Dubrovsky A, Dahan I, Eibauer M, Studt JD, Sapra KT, Varon D, Medalia O.

J Struct Biol. 2016 Mar;193(3):181-187. doi: 10.1016/j.jsb.2015.12.013. Epub 2016 Jan 6.

PMID:
26767592
10.

Roll, adhere, spread and contract: structural mechanics of platelet function.

Sorrentino S, Studt JD, Medalia O, Tanuj Sapra K.

Eur J Cell Biol. 2015 Mar-Apr;94(3-4):129-38. doi: 10.1016/j.ejcb.2015.01.001. Epub 2015 Jan 20. Review.

PMID:
25655000
11.

Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers.

Beeler PE, Eschmann E, Schumacher A, Studt JD, Amann-Vesti B, Blaser J.

J Am Med Inform Assoc. 2014 Oct;21(e2):e297-303. doi: 10.1136/amiajnl-2013-002225. Epub 2014 Mar 26.

12.

Heparin-induced thrombocytopenia associated with thrombotic microangiopathy.

Studt JD, Binet I, Nair G, Schanz U.

Hamostaseologie. 2013 May 29;33(2):160-3. doi: 10.5482/HAMO-13-03-0012.

PMID:
23715106
13.

Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response.

Schaller M, Studt JD, Voorberg J, Kremer Hovinga JA.

Hamostaseologie. 2013 May 29;33(2):121-30. doi: 10.5482/HAMO-12-12-0023. Epub 2013 Feb 27. Review.

PMID:
23443151
14.

Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.

Sigle JP, Infanti L, Studt JD, Martinez M, Stern M, Gratwohl A, Passweg J, Tichelli A, Buser AS.

Transfusion. 2013 Aug;53(8):1788-97. doi: 10.1111/j.1537-2995.2012.03959.x. Epub 2012 Nov 26.

PMID:
23176347
15.

Dronedarone reduces arterial thrombus formation.

Breitenstein A, Sluka SH, Akhmedov A, Stivala S, Steffel J, Camici GG, Riem HH, Beer HJ, Studt JD, Duru F, Luscher TF, Tanner FC.

Basic Res Cardiol. 2012 Nov;107(6):302. doi: 10.1007/s00395-012-0302-4. Epub 2012 Sep 29.

16.

Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.

Rovó A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M, Waltimo T, Studt JD, Tyndall A, Gratwohl A, Tichelli A.

Haematologica. 2011 Jan;96(1):150-5. doi: 10.3324/haematol.2010.030874. Epub 2010 Sep 17.

17.

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.

Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M, Flückiger U, Gratwohl A, Halter J, Hirsch HH.

Transpl Infect Dis. 2009 Apr;11(2):100-5. doi: 10.1111/j.1399-3062.2008.00362.x. Epub 2009 Jan 20.

PMID:
19175540
18.

[Thrombotic microangiopathies].

Studt JD.

Hamostaseologie. 2008 Dec;28(5):358-64. Review. German.

PMID:
19132166
19.

Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis.

Rovó A, Daikeler T, Stern M, Halter J, Studt JD, Buser A, Heim D, Rischewski J, Medinger M, Tyndall A, Gratwohl A, Tichelli A.

Blood. 2008 Feb 1;111(3):1740-1. doi: 10.1182/blood-2007-10-115964. No abstract available.

20.

Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS 13 deficiency?

Krieg S, Studt JD, Sulzer I, Lämmle B, Kremer Hovinga JA.

Thromb Haemost. 2005 Dec;94(6):1186-9.

PMID:
16411392
21.

The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).

Kremer Hovinga JA, Studt JD, Lämmle B.

Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):417-21. Review.

22.

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin.

Studt JD, Kremer Hovinga JA, Antoine G, Hermann M, Rieger M, Scheiflinger F, Lämmle B.

Blood. 2005 Jan 15;105(2):542-4. Epub 2004 Sep 14.

23.

Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas.

Tripodi A, Chantarangkul V, Böhm M, Budde U, Dong JF, Friedman KD, Galbusera M, Girma JP, Moake J, Rick ME, Studt JD, Turecek PL, Mannucci PM.

J Thromb Haemost. 2004 Sep;2(9):1601-9.

24.

Thrombotic thrombocytopenic purpura.

Lämmle B, Kremer Hovinga J, Studt JD, Mansouri Taleghani B, Alberio L.

Hematol J. 2004;5 Suppl 3:S6-11. Review. No abstract available.

PMID:
15190269
25.

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, Solenthaler M, Alberio L, Zwicky C, Fontana S, Taleghani BM, Tobler A, Lämmle B.

Haematologica. 2004 Mar;89(3):320-4.

26.

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.

Studt JD, Kremer Hovinga JA, Radonic R, Gasparovic V, Ivanovic D, Merkler M, Wirthmueller U, Dahinden C, Furlan M, Lämmle B.

Blood. 2004 Jun 1;103(11):4195-7. Epub 2004 Feb 24.

27.

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.

Klaus C, Plaimauer B, Studt JD, Dorner F, Lämmle B, Mannucci PM, Scheiflinger F.

Blood. 2004 Jun 15;103(12):4514-9. Epub 2004 Feb 19.

28.
29.

Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.

Fontana S, Kremer Hovinga JA, Studt JD, Alberio L, Lämmle B, Taleghani BM.

Semin Hematol. 2004 Jan;41(1):48-59.

PMID:
14727259
30.

Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.

Studt JD, Böhm M, Budde U, Girma JP, Varadi K, Lämmle B.

J Thromb Haemost. 2003 Sep;1(9):1882-7.

31.
32.

Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2.

Winkler A, Kremer Hovinga JA, Bianchi V, Studt JD, Lämmle B.

Hamostaseologie. 2003 Aug;23(3):103-8. Erratum in: Hamostaseologie. 2003 Nov;23(4):62.

PMID:
12923577
33.

Discrepant activity levels of von Willebrand factor-cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura.

Studt JD, Kremer Hovinga JA, Furlan M, Lämmle B.

Blood. 2003 Aug 1;102(3):1148. No abstract available.

34.

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE.

Blood. 2003 Jul 1;102(1):60-8. Epub 2003 Mar 13.

35.

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

Antoine G, Zimmermann K, Plaimauer B, Grillowitzer M, Studt JD, Lämmle B, Scheiflinger F.

Br J Haematol. 2003 Mar;120(5):821-4.

PMID:
12614216
36.

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.

Studt JD, Budde U, Schneppenheim R, Eisert R, von Depka Prondzinski M, Ganser A, Barthels M.

Am J Clin Pathol. 2001 Oct;116(4):567-74.

PMID:
11601142
37.

A distributed approach to integrated inquiry and display for radiology.

Wimmer MS, Blaine GJ, Jost RG, Moore SM, Studt JW.

J Med Syst. 1991 Aug;15(4):299-309.

PMID:
1800601
38.

[Diabetic autonomic neuropathy of the heart and its treatment with thioctic acid].

Studt J, Heuer LJ.

Dtsch Z Verdau Stoffwechselkr. 1984;44(4):173-80. German.

PMID:
6434286
39.
40.

[The hypocalcemic effect of mithramycin].

Heuer LJ, Zengel WR, Studt J.

Ther Ggw. 1979 Jul;118(7):1056-74. Review. German. No abstract available.

PMID:
158229
41.

[Diuretic agents in urine extracts: clearance studies, tubular glucose absorption and blood pressure].

Heuer LJ, Studt J.

Arzneimittelforschung. 1979;29(3):549-51. German.

PMID:
582743
42.

Microtubules and Duchenne muscular dystrophy.

Shay JW, Cook J, Fuseler JW, Feit H, Thomas LE, Studt JL.

Trans Am Neurol Assoc. 1979;104:12-5. No abstract available.

PMID:
553386
43.
44.

Supplemental Content

Support Center